1-198663227-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002838.5(PTPRC):​c.73+23886C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 152,054 control chromosomes in the GnomAD database, including 10,044 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 10044 hom., cov: 32)

Consequence

PTPRC
NM_002838.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.415

Publications

10 publications found
Variant links:
Genes affected
PTPRC (HGNC:9666): (protein tyrosine phosphatase receptor type C) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jun 2012]
PTPRC Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • T-B+ severe combined immunodeficiency due to CD45 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002838.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPRC
NM_002838.5
MANE Select
c.73+23886C>T
intron
N/ANP_002829.3
PTPRC
NM_080921.4
c.73+23886C>T
intron
N/ANP_563578.2P08575-4
PTPRC
NM_001267798.2
c.73+23886C>T
intron
N/ANP_001254727.1M9MML4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPRC
ENST00000442510.8
TSL:1 MANE Select
c.73+23886C>T
intron
N/AENSP00000411355.3P08575-3
PTPRC
ENST00000348564.12
TSL:1
c.73+23886C>T
intron
N/AENSP00000306782.7P08575-4
PTPRC
ENST00000530727.5
TSL:1
c.73+23886C>T
intron
N/AENSP00000433536.2E9PKH0

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53630
AN:
151936
Hom.:
10033
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.477
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.679
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.395
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.348
Gnomad OTH
AF:
0.378
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.353
AC:
53660
AN:
152054
Hom.:
10044
Cov.:
32
AF XY:
0.358
AC XY:
26638
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.281
AC:
11639
AN:
41486
American (AMR)
AF:
0.386
AC:
5890
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1224
AN:
3468
East Asian (EAS)
AF:
0.678
AC:
3508
AN:
5172
South Asian (SAS)
AF:
0.463
AC:
2234
AN:
4820
European-Finnish (FIN)
AF:
0.395
AC:
4166
AN:
10560
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.348
AC:
23682
AN:
67958
Other (OTH)
AF:
0.384
AC:
808
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1739
3478
5216
6955
8694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
15293
Bravo
AF:
0.349
Asia WGS
AF:
0.573
AC:
1993
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.1
DANN
Benign
0.68
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1998843; hg19: chr1-198632356; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.